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Thecompositionofcolonicmircoﬂoraanditschangeswithmaturationhaverarelybeeninvestigatedinlargesamples. Methods. We
used conventional microbiological testing to analyse the colonic ﬂora (Kyberstatus, Institut forMicroecology, Herborn, Germany)
of stool samples from 12 484 children with diﬀerent intestinal and nonintestinal diagnoses. Stool samples were analysed for total
colony forming units (CFU) (per g stool) and the abundance of Biﬁdobacteria, Bacteroides sp., Escherichia coli, Enterococcus sp., and
Lactobacillus sp. with respect to age, gender. A subset of 1089 infants was analysed for monthly changes within the ﬁrst year of life.
Results. Total CFU and individual microbial species were highest during the ﬁrst year of life, decreased within the ﬁrst 2 years, and
then stabilized for the remaining childhood. In infants, the total CFU rose until month 5, declined with weaning, and peaked at
9–10 months. Signiﬁcant eﬀects of age, but not of gender, were found in Bacteroides sp. and Lactobacilli. However Bacterioids sp.
andLactobacilli increasedwithage,whileEnterococci andE.colidecreased,andBiﬁdobacteriaremainedstable.Conclusion.Colonic
microﬂora show both a bacteria-speciﬁc and general pattern of maturation which is most profound within the ﬁrst year.
Copyright © 2009 P. Enck et al. This is an open access article distributed under the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Age-relatedchangesintheabundanceofnonpathogenicbac-
teria found in the human colon have rarely been investigated
in larger samples, neither in patients with intestinal and
nonintestinal disorders nor in healthy subjects. In contrast,
the eﬀects of maturation on colonic ﬂora in infants and
children have occasionally been studied, but mostly in small
cohorts of children.
Deviations in colonic ﬂora have been shown to be
responsible for respiratory diseases [1], intestinal diseases
[2],and,especially,dermatologicdisorders[3–6]inthepedi-
atric population. It has, for example, been argued that the
amount of exposure to commensal and pathogenic bacteria
in the very early days of life, such as following a Cesarian
section, [7] may contribute to the occurrence of atopic der-
matitis later in life [8]. A similar argument is the basis for the
“hygiene hypothesis” [9] ,w h i c ha r g u e st h a tg r e a t e re x p o s u r e
to environmental pathogens during childhood, for example,
while growing up on a farm or having contact with animals,
wouldprotectforimmunologicallymediateddiseaseslaterin
life [10, 11], but this is still a matter of debate [12]. However,
the importance of commensal microbiota for the develop-
ment of normal innate immunity is well established [13].
One reason for the relative absence of large-scale inves-
tigations is the suspicion that bacterial colonies found in
stool samples would not remain stable during transport
and storage; therefore. providing an inaccurate estimate of
bacterial counts when conventional microbiological tools are
used. Hence, commercial assays for fecal microbiota have
not been a widely accepted diagnostic tool in routine clinical
assessment. One exception is the use of fecal microbiota in
the diagnosis of the inﬂammatory bowel diseases, especially
Crohn’s disease and ulcerative colitis, since these are strongly
associated with Clostridium diﬀ. colonization in both chil-
dren [14] and adults [15].
Both the recent interest in prebiotic and probiotic
treatment for functional intestinal [16, 17], other intestinal2 Gastroenterology Research and Practice
[18–21], and nonintestinal disorders [12–26], along with
the availability of new molecular biological tools that are
able to count diﬀerent species, identify genetically diﬀerent
subspecies within each strain, and characterize normal
human colonic microbiota and its variability, have created
a new surge in research. Investigations regarding the eﬀect
of maturation on microbiota during childhood [27]a n d
its change with aging [28] have recently been performed.
However, as with most studies based on conventional micro-
biology, sample sizes have remained rather small thus far, as
PCR technology is not yet easily available, and microarray
chip technology that allows for the assessment of all bacterial
species known to inhabit the human colon (in the range of
>1000) is still very costly. This may, however, change in the
near future.
The few studies that have assessed the eﬀects of matu-
ration on human fecal microbiota have shown that some
bacterial species decline in their abundance with age, while
other do not. This paper presents data from a large (>12,000
samples) conventional microbiological database of children
with various intestinal and nonintestinal symptoms and
diagnoses. Respective data regarding adult populations have
recently been published [29]. The underlying hypothesis of
this analysis is that the average bacterial abundance found
in patients with various diseases and medical conditions
may represent an approximation of what may be called
the “normal” human fecal microbiota. Our assessment is
based on conventional microbiological analyses that were
performedinacommerciallaboratorywithGLPcertiﬁcation
during the course of one year.
2.MaterialandMethods
2.1. Collection of Stool Samples for Microbiological Analysis.
During the course of one year (2006), all fecal samples that
weresubmittedbygeneralpractitionersforroutineindustrial
microbiological analysis of nonpathogen colonic bacterial
ﬂora (Kyberstatus, Institute for Microecology, Herborn,
Germany) were included in the study. In general, samples
reached the laboratory within one day and were processed
immediately.
Toensurethatthetransportdidnothaveanyeﬀectonthe
culturedspecies, a storage study was performedwith 20 fresh
samples. In short, 0.2g of faeces was serially diluted in 1mL
ofphosphate-buﬀeredsaline(PBS,pH7.2).Thesolutionwas
vortexed for 5 seconds and serially diluted (to 10
−9) in PBS,
pH 7.2. One mL of each dilution was plated onto enrichment
or selective agar media.
The remaining feces were stored for three days at a
temperature of 25◦C, which represents the average temper-
ature during shipment. Following the incubation period, the
samples were processed as described and the results were
compared. No signiﬁcant discrepancy in the cell counts of
the investigated microbiota could be detected within two
days. Thus, it was concluded that a shipment of less than two
days will have no eﬀect on the composition of the cultivable
microbiota. Only samples which arrived within one or two
days of shipment were included in the study.
2.2. Identiﬁcation and Enumeration of Microorganisms.
Viable bacterial cell counts in feces were enumerated on the
following selective media: Columbia blood agar (total cell
count; BioMerieux, N¨ urtingen, Germany), U3G agar (enter-
obacteriacae, enterococci; Heipha, Heidelberg, Germany),
Rogosa agar, (lactobacilli; Heipha), DIC agar (biﬁdobacteria;
Heipha), Schaedler agar (bacteroides; Heipha), and SPM
agar (clostridia; Heipha). Fecal samples were serially diluted
in 1mL of phosphate-buﬀered saline (PBS, pH 7.2) and
subsequently plated on selective agar plates by a fully
automated spiral plater capable of plating 12 agar plates
simultaneously. Subsequently, the plates were incubated
under either aerobic or anoxic conditions at 37◦Cf o ra t
least two days. Bacteria were ﬁrst identiﬁed by Gram staining
and colony morphologies. Additionally, identiﬁcations were
performed by the API and VITEK systems (bioM´ erieux). All
counts were recorded as the numbers of log10 CFU per mL of
sample.
The following bacteria were routinely analyzed: Clostrid-
ium sp., Biﬁdobacteria, Bacteroides sp., subdominant (E.
coli, Enterococcus sp., Lactobacillus sp.), and other bacteria
(Pseudomonas sp., Klebsiella sp., Proteus sp., Citrobacter sp.,
aerobic bacteria). Only bacteria that were identiﬁed in at
least50%oftherespectivesubsamples(mentionedhereafter)
were included into further analysis.
2.3. Additional Data. Since samples were from patients with
various clinical diseases (Table 1), we collected additional
data that was reported by the referring physician. This
included age, gender, the presumed clinical diagnosis, and
stool consistency and frequency. Stool pH was determined
in the laboratory.
2.4. Data Analysis. After the data had been made anony-
mous, it was provided for further statistical analysis. Prior
to the analysis, the sample was screened for identical patient
IDs, and any second or subsequent analysis was excluded.
Incomplete datasets were also excluded, except those where
only gender information was missing.
The total age distribution allowed for the identiﬁcation
of a childhood sample (n = 12.484) (Figure 1)a n da n
adult sample (n = 35.292). The adult study has been
published recently [29]. A subset of 1089 infants (<1y e a r )
was identiﬁed for the analysis of monthly changes within the
ﬁrst year of life.
TotalCFUwasanalysedaswellasthebacterialabundance
for the following microbiota; Biﬁdobacteria, Bacteroides sp.,
lactobacilli, E. coli,a n dEnterococcus sp. The percentage of
subjectsinwhichClostridiumsp.wasidentiﬁedwasevaluated
as well.
Prior to statistical analysis, data were normalized. The
CFU of individual cell populations were compared to the
total CFU identiﬁed by calculating the relative “abundance”
of each bacterial species as ((speciﬁc CFU/total CFU)∗100).
The subsets (infants, children) were analyzed separately
by ANOVAs for each bacterial count (abundance) with the
between factors “age” (in monthly intervals for the infants,
in yearly intervals for children) and “gender.” Post-hoc tGastroenterology Research and Practice 3
Table 1: Major diagnoses in children that initiated the stool
analysis.
Organ classes Main diagnoses Children
Gastrointestinal
Unspeciﬁed 1862
Irritable Bowel Syndrome 1188
Crohn’s disease 27
Ulcerative colitis 64
Diarrhea 771
Constipation 296
Candida 1061
Food Intolerance 238
Respiratory
Unspeciﬁed 663
Bronchitis 294
Sinusitis —
Asthma 103
Urogenital
Unspeciﬁed 27
Cystitis —
Genital mycosis —
Dermatologic
Unspeciﬁed 40
Dermatitis 256
Psoriasis 28
Acne —
Allergic
Allergy, unspeciﬁed 229
Neurodermititis 2184
Recurrent urticaria —
Pollinosis —
Allergic asthma 230
Food allergies 209
Respiratory allergies 106
Rheumatologic Arthritis —
Others
Infection defence weakness 402
Autoimmune diseases —
Malignom —
Missing 421
Total 10699
(85%)∗
∗ The remaining to the total of 12.484 are cases with unknown diagnoses.
tests with Bonferroni correction to account for multiple
comparisons were used to test for single diﬀerences (between
months and years, resp.) within each dataset. Pearson’s r
was computed to test for intercorrelation between single
measures. All data are given as mean ± SEM. A threshold
of 0.05 was set to indicate statistical signiﬁcance in all tests.
All data were analyzed using the SPSS Version 13 Statistical
Package.
3. Results
From the sample of 47,775, n = 12483 were children and
adolescents less than 18 years, and among them, n = 1089
were infants and babies less than one year of age. Their stool
samples wereanalyzedfora variety of clinical conditions (see
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Figure 1: Age distribution (in years) in male and female subjects
between 1 and 18 years.
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Figure 2: Total CFU (mean ± SEM) by age (months) and by
gender. “∗” indicate signiﬁcant diﬀerence in post-hoc T-test
(Bonferroni corrected). A number of boys and girls are infants
(604 : 459 m : f) plus children up to 2 years.
Table 1), but without any documentation of the diagnostic
accuracy.
3.1. Infants. The infant group (≤1 year) included 604 males
and 459 females, 6.47±0.92 months of age. ANOVA revealed
a signiﬁcant eﬀect of age (F = 3.94, P<001), but not
of gender on total CFU (Figure 2). As can be seen, CFU
increased within the ﬁrst few months, declined to a ﬁrst
low at the time of weaning, and exhibited a second peak at
months 10 and 11. It steadily declined thereafter to reach
stable levels at age 5 or 6 (described in what follows).
ANOVA showed signiﬁcant eﬀects of age, but not of
genderonindividualbacterialabundance.Allbacteriaexcept
Lactobacilli were present within the ﬁrst month of life.
However, Enterococci and E. coli decreased (F = 3.098, P<4 Gastroenterology Research and Practice
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Figure 3: Abundance (%) (mean± SEM) by age (months) of E.
coli, Enterococcus sp., as well as Lactobacillus sp., Biﬁdobacteria,a n d
Bacteroides sp.
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Figure 4: Total CFU (mean ± SEM) by age (years) and by gender.
.001 and F = 2.884, P = .001, resp.) while Bacteroides
sp. increased (F = 3.14, P<. 001), and Biﬁdobacteria
remained stable (F = 1.226, P = .265) within the ﬁrst
year. Lactobacilli existed at high concentrations at month 2,
but steadily decreased thereafter (F = 2.143, P = .016)
(Figure 3). The percentage of Clostridium sp. declined from
3t o2 % .
3.2. Children. For all the 12,483 children (6.02 ± 0.04 years,
6100 : 6074 male: female, remaining= missing), total CFU
signiﬁcantly declined (F = 126.74, P<. 001) from year 1 to
year 10 and remained stable thereafter. Overall, females had
a signiﬁcantly lower bacterial count than males (F = 19.24,
P<. 001) (Figure 4).
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Figure 5: Abundance (%) (mean± SEM) by age (years) of E.
coli, Enterococcus sp., as well as Lactobacillus sp., Biﬁdobacteria,a n d
Bacteroides sp.
Individual bacteria abundance showed the same age-
related decline within the ﬁrst few years for Enterococci
(F = 37.188, P<. 001) and Lactobacilli (F = 9.888,
P<. 001), while E. coli moderately decreased (F = 8.679,
P<. 001). Given the high proportion of their speciﬁc
CFU, the time proﬁle of Biﬁdobacteria and Bacteroides sp.
was almost complementary. Biﬁdobacteria decreased overall
(F = 34.051, P<. 001), while Bacteroides sp. increased
their proportion (F = 43.465, P<. 001) (Figure 5). An
independent eﬀect of gender was noted for Biﬁdobacteria
(F = 4.982, P = .026) and E. coli (F = 12.203, P = .001)
with higher values for Biﬁdobacteria,b u tl o w e rv a l u e sf o rE.
coliinmales(datanotshown).ThepercentageofClostridium
sp. remained low at around 2% (data not shown).
Stool consistency (rated between 1 = solid and 5 =
liquid) decreased (F = 16.108, P<. 001) and was
signiﬁcantly lower in females (F = 51.735, P<. 001). Stool
pH increased within the ﬁrst years (F = 74.425, P<. 001)
and was overall higher in females (F = 23.998, P<. 001)
(Figures 6(a) and 6(b)).
Moderate negative correlations were found between pH
and Biﬁdobacteria (r =− .33, P<. 001), and positive
correlations between pH and E. coli (r = .24, P<. 001).
4. Discussion
Newborns are germfree at the time birth, and acquire
bacteria from their immediate environment within the ﬁrst
hours of life: from their mothers’ vaginal and fecal ﬂora,
and from the hospital or home environment, depending
on the mode and location of delivery. Other factors that
can inﬂuence the composition of the intestinal microﬂora
in newborns are the environment during birth, maturity,
hygiene measures, and the type of infant feeding [30].Gastroenterology Research and Practice 5
2.1
2.2
2.3
2.4
2.5
2.6
2.7
2.8
2.9
S
t
o
o
l
 
c
o
n
s
i
s
t
e
n
c
y
 
(
m
e
a
n
 
+
 
S
E
M
)
0123 4 56789 10 11 12 13 14 15 16 17 18 19
Males
Females 
_
Age (years)
(a)
5.8
6
6.2
6.4
6.6
6.8
7
S
t
o
o
l
 
p
H
 
(
m
e
a
n
 
+
 
S
E
M
)
0123 4 56789 10 11 12 13 14 15 16 17 18 19
Males
Females
_
Age (years)
(b)
Figure 6: Stool consistency (mean ± SEM) (a) (1 = solid, 5 = liquid) and stool pH (mean ± SEM) (b) by gender and age (years).
Speciﬁcally, E. coli, Enterobacter sp.,a n dEnterococci
colonize the gastrointestinal tract rapidly, and are often
found in higher concentrations in newborns than in adults
due to the fact that aerobes and facultative anaerobes are
favored by the intestinal milieu at birth. When these species
expand, they consume oxygen and allow anaerobic strains to
follow, including Bacteroides, Biﬁdobacteria,a n dClostridia.
Lactobacilli are oxygen tolerant and are most likely derived
from the mothers’ fecal ﬂora [31]. Infants delivered by
Cesarian section do not come into contact with the maternal
ﬂora during delivery. Their colonization of Bacteroides sp.
is delayed. This has been shown to be responsible for the
development of atopic dermatitis later in life [32].
However, among infants, the variability of the composi-
tion and proﬁle of intestinal microbiota remains high [33]. It
is also subject to change according to diﬀerences in nutrition
[34] and other cultural inﬂuences [35], as well as host
genetics,whichexertastronginﬂuenceoverthecomposition
of the fecal microﬂora [36].
Therefore, the exploration of the “normal” range of
the gut microbiota composition during the development
and maturation remains a methodological challenge. In a
previous paper [29], we reported the data from a large
(>35.000 samples) adult cohort under the assumption that
the average bacterial abundance across all patients may
represent an approximation of what may be called the
“normal” human fecal microbiota. Using the current data
from the same source, we applied this argument to infants
and children.
In agreement with previous reports (summarized by
Adlerberths et al. [31]), we report a high total bacterial load
in the newborn intestine within the ﬁrst months after birth
that declines within the ﬁrst years of life to levels that are
maintained during childhood and thereafter [29]. The total
CFU may also reﬂect changes associated with weaning, since
a local trough can be found (see Figure 2)a ta r o u n da g e
7 months, which may reﬂect this change in nutrition. This
seems somewhat counter-intuitive, as one would expect to
ﬁ n da ni n c r e a s ei nt h eC F Uo n c em o r et y p e so ff o o d sa r e
introduced in the diet. However, weaning may induce an
initial decline of predominantly lactate acid metabolizing
bacteria while other species may follow colonizing the colon
at a slower rate.
During the ﬁrst year, the composition of the microbiota
changes. E. coli and Enterococci decline, while Bacteroides sp.
increases 3-folds. Biﬁdobacteria B. in the infant stool samples
remained stable during the ﬁrst years. Diﬀerent from many
previous reports [31], Lactobacilli were not present during
the ﬁrst month, but represented as much as 10% of the
identiﬁed CFU one month later (Figure 3). Controversy in
literature on whether or not Lactobacilli are part of the early
gut colonizers has been noted [31], and it has been stated
that the Lactobacilli colonizing the infant’s gut are likely
not from their mothers’ vaginal ﬂora [37], but rather from
maternal gut ﬂora. Colonization with Lactobacilli is delayed
after Cesarian section, but reported to be normal one month
later [38]. Since we do not know the route of birth in our
sample, we cannot exclude that this may be the cause of the
late occurrence of LB in our study. Other reasons postulated
[31] for this discrepancy are diﬀerences in the methods used
to identify Lactobacilli,o rd i ﬀerences in the colonization
pattern during the last decades, as many studies derive from
work earlier than 1990.
During the remaining childhood up to age 10, the total
CFU constantly declines to levels at about 2 × 10 E11
(see Figure 4), while individual strains reach stable levels at
age 3 (see Figure 5). These ﬁndings also support previous
reports [4, 31] .S i m i l a rt oo u ra d u l ts a m p l e[ 29], females
had signiﬁcantly lower stool consistency (towards more solid
stools) and higher stool pH. Although both measures are
not linked, they likely express the same function. We cannot
exclude, however, that this may be due to diﬀerences in body6 Gastroenterology Research and Practice
weight and/or body mass. Unfortunately, the database did
not allow adjusting for this.
Several other limitations of our analysis need to be
addressed. One is that methods based on bacterial culture
might not detect all species of the human microbiota.
Additionally, obligate anaerobic bacteria might be at a
disadvantage, and, therefore, the proportion of anaerobic
bacteria to aerobic bacteria might not reﬂect the ratios in
vivo. However, direct comparison of conventional culture
analyses and molecular techniques have produced similar
results, at least for the most abundant bacteria [39]. Other
limitations refer to missing clinical data on medication
intake, such as antibiotics. Nutritional habits and regular
consumption of pre- and probiotic products may also
have corroborated the results. For example, breastfeeding
markedly inﬂuences the microbiotic ﬂora in infants as does
type of formula consumed and the time that supplementary
food is introduced. Thus, we can only give an approximation
of what may be called the ‘normal’ human faecal microbiota
for this time period. Furthermore, the use of antibiotics
severely inﬂuences intestinal ﬂora. Since bacterial infection
of the upper and lower respiratory tract is quite common,
many children receive antibiotics during the ﬁrst year of
life. As these data were missing in our dataset, we cannot
generalize our assumption. However, as stated in a previous
paper[29],wereportedthedatafromalargeinfantandchild
cohort (>12,000 samples) under the assumption that the
average bacterial abundance across all patients may represent
an approximation of what may be called the “normal”
human fecal microbiota during infancy and childhood.
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